Anne–Marie Langevin, MD

Abstract

Lipsitt AE,
Diaz VR,
Hung J,
Weitman S,
Langevin AM. Complete Remission in a Young Adult with Recurrent Extranodal NK/T-cell Lymphoma Treated on the iMATRIX Early-Phase Open-Label Atezolizumab Trial (GO29664); 2018 Jul. (POETIC Summer Meeting - 2018). Lopez MP,
Diaz VR,
Langevin AM. Localized Translation and Real-Time interpretation of Informed Consent Forms in Pediatric Oncology Clinical Trial Participation; 2018 Feb. (Advancing the Science of Cancer in Latinos - Inaugural Meeting San Antonio 2018). Higgerson K,
Langevin AM,
Rajani R,
Heim-Hall J,
Hung J,
Sugalski AJ. Characterization of Localized Osteosarcoma of the Extremity in Children, Adolescents, and Young Adults from South Texas: Increasing Insight into Hispanic Populations; 2018 Feb. (Advancing the Science of Cancer in Latinos - Inaugural Meeting San Antonio 2018). Cruz A, Bensal H, Tomlinson M, Bansal S, Langevin AM, Weitman SD. Hydroxychloroquine in Combination with Vorinostat to Improve Response in Pediatric Solid Tumor Cell Lines; 2017 Mar. (POETIC Winter Meeting - 2017). Trippett T, Rossato G, Langevin AM, Michon J, Frappas D, Locatelli F, Kowgler M, Tagen M, Kwan A, Das Thakur M, Georger B. A Phase I/II study of atezolizumab in pediatric and young adult patients with refractory/relapsed solid tumors (iMATRIX-Atezolizumab); 2017 Jan. (49th Annual SIOP Meeting 2017). Hung JY; Heim-Hall J; Chen Y; Langevin AM. MicroRNA signatures in osteosarcoma associated with clinical outcome; 2013 Sep. (Pediatric Blood and Cancer - SIOP 45th Congress).

Journal Article

Langevin AR. Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy Pediatric Blood and Cancer 2018 Dec;. Dupuis LL
Kelly KM
Krischer JP
Langevin AM
Tamura RN
Xu P
Chen L
Kolb EA
Ullrich NJ
Sahler OJZ
Hendershot E
Stratton A
Sung L
McLean TW. Acupresure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: a single-blinded randomized controlled trial Cancer 2018 Mar;124(6):1188-1196. Joanne P. Lagmay, Mark Krailo, Ha Dang, AeRang Kim, Douglas Hawkins, Mason Bond, Orren Beaty, Brigette Widemann, Ted Zwerdling, Lisa Bomgaars, Anne-Marie Langevin, Holcombe Grier, Brenda Weigel, Richard Gorlick, Katherine Janeway. Outcome of recurrent osteosarcoma patients enrolled in seven phase II trials through CCG, POG, and COG: Learning from the past to move forward Journal of Clinical Oncology 2016 Sep;34(25). Patel Priya
Robinson, Paula D
Orsey, Andrea
Freedman, Jason L
Langevin AR
Woods Debbie
Sung Lillian
Dupuis Lee. Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children?s Oncology Group Pediatric Blood and Cancer 2016 May;:1-6. Roth, Michael
O`Mara, Ann
Seibel, Nita
Dickens, David
Langevin AR
Pollock, Brad
Freyer, David. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program Journal of Oncology Practice 2016 Apr;. Bartanusz V, Ziu M, Jimenez DF, Crownover RL, Langevin AM. Zoledronic acid therapy for recurrent giant cell tumor of the C2 vertebra in an adolescent Spine J 2015 Mar;15(8):1886-1887. Patricia C. Sanchez-Diaz, Tzu-Hung Hsiao1, Yi Zou1, Aaron J. Sugalski, Josefine Heim-Hall, Yidong Chen, Anne-Marie Langevin, Jaclyn Y. Hung1. In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma Oncoscience 2014 Sep;.